DE2313256C3 - l^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel - Google Patents

l^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel

Info

Publication number
DE2313256C3
DE2313256C3 DE2313256A DE2313256A DE2313256C3 DE 2313256 C3 DE2313256 C3 DE 2313256C3 DE 2313256 A DE2313256 A DE 2313256A DE 2313256 A DE2313256 A DE 2313256A DE 2313256 C3 DE2313256 C3 DE 2313256C3
Authority
DE
Germany
Prior art keywords
ethanol
benzisoxazole
acid
solution
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2313256A
Other languages
German (de)
English (en)
Other versions
DE2313256B2 (de
DE2313256A1 (de
Inventor
Tetsuo Settsu Hirooka
Mikio Kobe Hyogo Kurokawa
Yoshinobu Osaka Masuda
Haruki Ikeda Osaka Nishimura
Masanao Kobe Hyogo Shimizu
Hitoshi Takatsuki Uno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of DE2313256A1 publication Critical patent/DE2313256A1/de
Publication of DE2313256B2 publication Critical patent/DE2313256B2/de
Application granted granted Critical
Publication of DE2313256C3 publication Critical patent/DE2313256C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2313256A 1972-03-17 1973-03-16 l^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel Expired DE2313256C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2786572A JPS5545545B2 (https=) 1972-03-17 1972-03-17

Publications (3)

Publication Number Publication Date
DE2313256A1 DE2313256A1 (de) 1973-09-20
DE2313256B2 DE2313256B2 (de) 1979-09-20
DE2313256C3 true DE2313256C3 (de) 1980-06-12

Family

ID=12232783

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2313256A Expired DE2313256C3 (de) 1972-03-17 1973-03-16 l^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel

Country Status (4)

Country Link
JP (1) JPS5545545B2 (https=)
BE (1) BE796889A (https=)
DE (1) DE2313256C3 (https=)
ZA (1) ZA731847B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427691A (en) 1981-02-25 1984-01-24 Hoechst-Roussel Pharmaceuticals Inc. 1,2-Benzisoxazoloxyethylamines and intermediates for the preparation thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862035D1 (en) * 1977-11-30 1982-11-04 Merck & Co Inc Substituted nitroimidazoles, process for their preparation and compositions containing them
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4957931A (en) * 1987-07-08 1990-09-18 Ciba-Geigy Corporation Certain 1,2-benzisoxazole and 1,2-benzisothiazole derivatives
US4859691A (en) * 1987-07-08 1989-08-22 Ciba-Geigy Corporation Certain 1,2-benzisoxazole derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427691A (en) 1981-02-25 1984-01-24 Hoechst-Roussel Pharmaceuticals Inc. 1,2-Benzisoxazoloxyethylamines and intermediates for the preparation thereof

Also Published As

Publication number Publication date
ZA731847B (en) 1973-12-19
DE2313256B2 (de) 1979-09-20
BE796889A (fr) 1973-09-17
JPS4892367A (https=) 1973-11-30
DE2313256A1 (de) 1973-09-20
JPS5545545B2 (https=) 1980-11-18

Similar Documents

Publication Publication Date Title
DE2503815C2 (de) Indazol-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
WO2006018222A1 (de) Hydrate und polymorphe des 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamid, verfahren zu deren herstellung und deren verwendung als arzneimittel
CH652395A5 (de) 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen.
DE1695139A1 (de) Verfahren zur Herstellung von Imidazolderivaten
CH641159A5 (de) Verfahren zur herstellung von neuen guanidinderivaten.
AT368131B (de) Verfahren zur herstellung von neuen 9-aminoalkyl- fluorenen und von deren salzen
CH649995A5 (de) Piperazinderivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten.
DE2313256C3 (de) l^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
CH668973A5 (de) Purin-derivate, ihre herstellung und sie enthaltende arzneimittel.
DE2817083A1 (de) Benzylisochinolin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
EP0018360A1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung.
DE1643197A1 (de) Diarylcyclopropanderivate und Verfahren zu ihrer Herstellung
DD154487A5 (de) Verfahren zur herstellung von 1-benzoxepin-5(2h)-on-derivaten
CH666035A5 (de) 8-alpha-acylaminoergolene.
DE1817740C3 (https=)
DE2012667C3 (de) 3- (4-substituierte-1-Piperazinyl)-carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate
DE3204074C2 (https=)
DE2310827C3 (de) Im phenylkern heterocyclisch substituierte Phenylalaninderivate
DE2756852A1 (de) 1-amino-niedrig-alkyl-3,4-diphenyl- 1h-pyrazole
EP0478941B1 (de) Arzneimittel welche substituierte 2-Cyclohexen-1yl-amin-Derivate enthalten und ihre Verwendung zur Bekämpfung von Krankheiten
DE2511802A1 (de) Alkoxyanilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69223262T2 (de) Benzimidazolderivate, verfahren zur herstellung, zwischenprodukte, und diese als aktive bestandteile enthaltende antiemetische substanzen
EP0003298A2 (de) 4-Hydroxy-2-benzimidazolin-thion-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
OD Request for examination
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee